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Abstract
Background: - Nausea and vomiting is multifactorial and common problem after spinal
anaesthesia for cesarean section which can be unpleasant and disturbing to the patient and
making surgery difficult. So that it is sensible to administer prophylaxis drugs with gastrokenitic
and antiemetic property for emergency caesarean section. Metoclopramide is believed to be
effective to reduce both the incidence and severity of intraoperative and early postoperative
nausea and vomiting for cesarean section in some studies. But its effectiveness of reducing the
risk of nausea and vomiting after spinal anesthesia for emergency cesarean section was
undetermined in our country, Ethiopia. There may be variation in the population demographics
and anaesthetic and surgical managements.
Objective: - the aim of this study was to assess the effectiveness of metoclopramide
prophylaxis for intraoperative and early postoperatve nausea and vomiting after emergency
cesarean section under spinal anaesthesia at GUH.
Methods: - prospective observational study was conducted to assess the effectiveness of
metoclopramide.  Patients  who took  10mg metoclopramide prophylaxis were grouped as group
A and without prophylaxis were grouped as group B. pretested observational checklist and
interview questionnaire were used to collect the data during CS, and at the 2st , 4nd and 6th hour
after cesarean section. Descriptive statistics was calculated for most variables. Student t test or
Mann Whitney U tests were used when appropriate. Chi-square and Fisher exact tests were used
to compare the proportion of categorical variables between the groups.
Results: - The prophylaxis group with 10mg metoclopramide (n=66) compared with non
prophylaxis group (n=66) resulted a significant reduction in the overall incidence of
intraoperative and early postoperative nausea and vomiting (25.8% vs. 48.5%, p=0.007). The
median score for nausea on a linear numeric rating scale were also reduced in the prophylaxis
group [0(0-7) vs. 0 (0-9), p=0.037] at the end of CS and [0(0-6) vs.  0 (0-9), p=0.006] at 2hour
and [0(0-6) vs. 0 (0-8), p=0.031] at 4hour. The frequency and number of vomiting episode was
also significantly reduced in the prophylaxis group.
Conclusion and recommendation: - Metoclopramide can reduce the incidence and severity
of nausea and vomiting when used as prophylaxis before emergency cesarean section under
spinal anesthesia.
viii
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11. Introduction
1.1 Statement of the Problem
Nausea and vomiting is a very common anaesthetic complication during and after cesarean
section under spinal Anaesthesia. From previous studies reported without prophylaxis antiemetic
the incidence extremely varies; up to 80% [1, 2]. Nausea and vomiting may result significant
distress to the patient and also interfere with the surgical procedure. Consequently it may result
aspiration of vomitus, postoperative bleeding and wound dehiscence. The liability of pregnant
mothers to nausea and vomiting can be due to hormonal changes to pregnancy attributed by
impaired motility of the esophagus, stomach and small bowel as a result of smooth muscle
relaxation.[3] The etiology of intraoperative nausea and vomiting is complex; it may be attributed
by patient demographic, anesthetic and non-anesthetic causes.[1] Hypotension, surgical stimuli,
bleeding during surgery, and uterotonic agents are common offending anaesthetic and surgical
causes. As Apfel et.al and similar studies stated previous history of PONV, female gender,
motion sickness, none smoking status, longer duration of surgery and use of IV opioids are
predictive factors which may affect the occurrence of postoperative nausea and vomiting in the
general population. [4, 5]
On the other hand most studies suggested no single intervention is available to eliminate nausea
and vomiting completely during cesarean section under spinal anaesthesia; which in fact relied
on the anesthetic and surgical techniques used, relative preventive measures taken and
multimodal approaches used for superior results than monotherapy in the presence of multiple
risks.[2, 6-13] In this regard;  strict control offending  anaesthetic and surgical factors by adequate
preloading/ co-loading with fluids, administration prophylactic vasopressors and 15 degree left
uterine displacement[10, 11, 13, 14], optimal use of neuraxial opioids and limited use of systemic
opioids, improvement of the surgical techniques, as well as judicious and slow administration of
uterotonic agents are believed to be preventive measures to reduce nausea and vomiting[15].
Many systematic reviews and randomized trials have been done to assess of the efficacy of
metoclopramide prophylaxis for postoperative nausea and vomiting after elective cesarean
section when used as monotherapy or in combination with others.[7, 16-18] Majority of these
studies showed administration of 10mg metoclopramide prior to spinal blockage was effective
and safe to prevent IONV and early PONV elective caesarean section under regional
2anaesthesia.[16, 19] But most of these studies were conducted under control of major intraoperative
anesthetic and surgical predisposing factors predictor risks of NV. However in poor setup the
availability and applicability of preventive measures for better control of nausea and vomiting in
the case of emergency cesarean section questionable.
31.2. Literature Review
Nausea and vomiting after spinal anaesthesia for caesarean section is multifactorial.[20]
Hypotension occurring during spinal anesthesia for cesarean section is one of the most important
factors.[1, 21] which may trigger the vomiting centre to induce emesis due to hypoxia. And the
cause of nausea and vomiting due to hypotension was largely related to spinal anesthesia
particularly during higher segmental sympathetic blockade and aortocaval compression [22] and
partly when there is fast administration of iv bolus oxytocin as a result of vasodilation.[23] In this
regard a bolus lower doses of oxytocin during caesarean section was resulted in less
haemodynamic changes than a 5 unit bolus when given before 10u/hour continuous infusion of
oxytocin doses.[8, 24] On the other hand intravenous injection of ergometrine found to be less
hemodynamic instibilation but can have nausea and vomiting by interaction with dopaminergic
and serotinonergic alpha-adrenergic receptors. The incidence of NV was highest among the
uterotonic agents with 0.5 mg bolus. However, this drug is usually given intramuscularly which
may produce less emesis. [1] Administration of supplemental oxygen during surgery can relieve
nausea in such circumstances as previous studies found but recent controlled randomized studies
disproved its effectiveness to reduce the incidence of intra- and postoperative nausea and
vomiting in women undergoing elective cesarean section under subarachnoid block.[25] But
studies stated that distinct association of IONV were found with maternal hypotension and strict
control of blood pressure which can considerably decrease intraoperative emetic symptoms.[2, 10,
26, 27]
Systematic review from previous studies suggested strategies to prevent rather than treat
hypotension was found  to be more likely to decrease the incidence of nausea and vomiting.[10] In
this regard lateral uterine displacement, rapid preloading/ fluid co-hydration with 10- 20ml/kg
or 1000-1500ml crystalloids  and prophylactic vasopressors have been advocated in order to
avoid hypotension.[11] However; recent systematic reviews found preloading was unsuccessful to
reduce the incidence of relevant hypotension than co loading due to various reasons. This review
favored the use of prophylactic vasopressors or combined preload co- load is better than delaying
for preloading.
The other important contributing factor for the occurrence of IONV is surgical stimuli or
inadequate anesthesia which includes exteriorization of the uterus, intra-abdominal manipulation
and peritoneal traction during closure.[34, 35] These maneuvers produce visceral pain that is
4mediated by unmyelinated C-fibers.[28] In this regard a comparative study found incidence of
post partum nausea was significantly reduced when the uterus was repaired in situ as opposed to
after exteriorization( 38% vs. 15%) and vomiting was also reduced from 18% to 5%, but was
statistically insignificant.[29] On the other hand previous reviews studies stated that the use of
intrathecal or i.v opioids reduces the incidence of both IONV and PONV nausea and vomiting
by increasing quality of block and  reducing visceral pain during surgical manipulation.[9, 30, 31]
On the contrary one previous study found some of the commonly used intrathecal or i.v
administered opioids predispose to postoperative nausea and vomiting in a dose dependent
manner however; reduction the use of opioids was not followed by in the reduction of
postoperative nausea and vomiting.[32, 33] In addition intraoperative opioids were not a
statistically significant predictor from multivariate logistic regression analyses of a recent large
systematic review.[4]
Recent systematic reviews and mata analysis done in USA with eleven studies with 702 patients
using spinal anesthesia in nine studies and epidural anesthesia in two studies showed;
administration of 10mg Metoclopramide resulted in a significant reduction in the incidence of
ION and IOV when given before block placement [relative risk (RR) (95% CI) =0.27 (0.16,
0.45) and 0.14 (0.03, 0.56), respectively. The incidence of early (0–4 h) PON and POV [RR
(95% CI) =0.47 (0.26, 0.87) and 0.45 (0.21, 0.93), respectively. And overall (0–24 or 4–24 h)
PON (RR 0.69; 95% CI 0.52, 0.92) incidence were also reduced with administration of
metoclopramide before block placement.[16]
Comparative randomized double blind placebo controlled study in USA was done to determine
the efficacy and safety of 10mg intravenous metoclopramide administered prophylactically
before elective cesarean delivery under spinal anesthesia on 42 patients. those  patients in the
group receiving metoclopramide had a significantly lower incidence of nausea and vomiting both
before and after delivery than the control  group (saline) 14% and 81% respectively[34]. Similar
RCT conducted in India involving 80 elective cesarean sections to compare effects of
metoclopramide and other two antiemetic drugs with placebo showed that the incidence of
nausea and vomiting intraoperative and up to 4 hours postoperative  was 30% in the
metoclopramide group and 55% in saline group but the result was stastically insignificant.[35]
Similarly a recent randomized clinical trial study aimed to compare the effects of Acupressure
and Metoclopramide in 6hours postoperative nausea and vomiting was conducted on 102 patients
5in Caesarean Sections in Iran.  This study found the incidence of nausea (50% vs. 20%; p=0.03
with 95%CI) and vomiting (32.34%vs 11.76%; p value of 0.01 was significantly lower in
Metoclopramide group as compared that in the control group. And the severity of nausea and
vomiting within 6 hours after surgery was also significantly reduce with metoclopramide
compared with control group.[36]
1.3. Justification of the Study
Previous researches reported women without any prophylactic antiemetic were found higher
incidence of nausea and vomiting after caesarean section. The condition is expected to be worse
after emergency cesarean section due to presence of potential multiple anesthetic and surgical
risks of nausea and vomiting and shortage of time for preoperative optimization. As researches
showed in developed countries; in addition to antiemetic prophylaxis; measures to reduce the
risks of nausea and vomiting due to hypotension such as rapid rehydration and use of effective
prophylactic vasopressors and left lateral uterine displacement and intrathecal administration of
short acting opioids and adjuvant with local anesthetics used to reduce visceral stimulation were
identified preventive measures to contribute effective control of antiemetic  for nausea and
vomiting after cesarean section under spinal anaesthesia. However; the availability and use of
these measures to minimize the risks of nausea and vomiting are very limited in our country. But,
metoclopramide is a generic inexpensive drug with multiple sites of action which is reported to
be effective and safe for elective cesarean section. Recently it is advocated to use by some
anaesthetists in Gondar university hospital. But as far as our knowledge and search is concerned;
there was no previous study that could show the effectiveness of metoclopramide prophylaxis for
nausia and vomiting after emergency cesarean section under spinal anaesthesia in our country.
This study will enable to know wether or not this 10mg metoclopramide prophylaxis used by
anaesthetists before emergency caesarean section is effective to reduce the incidence of
intraoperative and early postoperative nausia and vomiting in our setup.
2. Objective
2.1. General Objective
To assess the effectiveness of metoclopramide prophylaxis for nausea and vomiting after
emergency cesarean section undern spinal anaesthesia at Gondar university hospital
62.2. Specific objectives
To compare the incidence of nausea and vomiting between metoclopramide prophylaxis and no
prophylaxis groups.
To compare severity of nausea between the groups
To compare number of episodes of vomiting between groups
3. Method
3.1. Study Design, Setting and Period
Hospital based prospective observational cohort study was conducted in Gondar university
hospital obstetric ward from March 8 to May 8, 2014. On average more than 100 emergency
cesarean sections done per month. For majority of cesarean sections spinal anesthesia is the first
line anaesthetic technique unless contraindicated by most of anaesthetists in Gondar university
hospital. Recently metoclopramide is available with low cost and advocated to use by MSc
students and senior anaesthetists as antiemetic prophylaxis for cesarean section. Observations for
this study were done in the obstetrics operation room and ward. Groups classified based on their
exposure status for metoclopramide (metoclopramide prophylaxis groups and no
metoclopramide prophylaxis group) after cesarean section
3.2. Source and study Population
3.2.1. Source population
All women who was delivered by emergency cesarean section under spinal anaesthesia at the
University of Gondar hospital
3.2.2. Study population
All women who was delivered by emergency cesarean section under spinal anaesthesia at the
University of Gondar hospital
3.3. Inclusion and Exclusion Criteria
3.3.1. Inclusion criteria
All healthy term pregnancy mothers who had emergency caesarean section under spinal
anesthesia with available local anestahetics were included in the study.
3.3.2. Exclusion criteria
Any mother having acute or chronic medical illness associated with nausea and vomiting within
24 hours was excluded. Mother who received antiemetic meditation within 24 hours before
7surgery indicated. Patients who were given propofol, ketamine, atropine or adrenaline in the intra
operative period were excluded. Or mothers who had a concurrent use of an alternative
multimodal anti-emetic regimen in the study period were excluded. In addition mothers who had
diagnosis of APH and PPH during the study period were excluded.
3.4. Variables
3.4.1. Dependent variable
Nausea and vomiting
3.4.2. Independent variables
Demographic factors: age, weight, height, ASA status, gestational age and parity, previous
history of PONV or motion sickness and history of smoking status.
Anesthetic and surgical management: perioperative medications such as opioids, uterotonic
agents, antibiotics, and amount of fluid preloaded/coloaded , total intraoperative fluid, type of
local anesthetics administered and level of sensory block, duration of surgery/uterus exteriorized,
pain, hemodynamic changes( BP, PR, Sao2) after spinal anaesthesia and intraoperative and
postoperative analgesics given and supplemental oxygen.
3.5. Operational Definitions
To say the patient has intraoperative and early postoperative nausea and vomiting following
cesarean section under spinal anaesthesia, a patient must have at least one episode of nausea,
vomiting or both (retching considered as vomiting) in the intraoperative and early (0–6 hours)
postoperative period. Severity of nausea was described with 10-mc linear numeric scale (0
without nausea or vomiting,10=very severe nausea ).[36] The decrease in systolic blood pressure
> 20% of baseline values and/or less than 100 mm Hg immediately after spinal injection will be
considered as hypotension.
Amount of fluid co loaded – amount of fluid administered within 20 minutes after spinal
placement.
Total amount of fluid administered during operation - total amount of intravenous fluid given
starting spinal tap until the end of operation.
Duration of uterus exteriorized - the time when the uterus lifted out of the abdominal cavity
during uterine repair.
8Sever post anaesthesia shivering refers to patient experiencing more than 3 score of shivering or
that manifested with body movement.
Level of spinal block=
3.6. Sampling Technique
3.6.1. Sample Size and Sampling Technique
There is no documented study that shows the incidence of nausea and vomiting (NV) after spinal
anaesthesia for cesarean section in study area. However; from recent studies in abroad over all 24
hours incidence of nausea and or vomiting after spinal anaesthesia for cesarean section ranges
from 40% to 80% when no prophylactic antiemetic is given.[37] On the other hand based on
Apfel simplified risk score and rule of thumb including patients with at least two risk factors
assumed to result an average 50% predicted incidence of postoperative nausea and or
vomiting.[38] Using proportion difference sample size calculation formula, sample of 66
candidate parturients in each group were calculated  to detect 25 % difference(as RCT used)
between the groups with 5% alph error at a power of 80%.
3.7. Data Collection procedures
The data were collected using prospective self structured observation checklist and interview-
based questionnaire. Candidate parturients were identified and coded by principal investigator
based on no prophylaxis given or administration of 10 mg metoclopramide by the responsible
anaesthetist within 30 minutes before spinal anaesthesia for caesarean section. The preoperative
and intraoperative anaesthetic and surgical managements were continuously observed by one
data collector free from the intraoperative anaesthesia management. Oxygen saturation, pulse
rate and systolic blood pressure of each woman was monitored and recorded every 5 minutes
during the surgery and every one hour post-operatively during the study period. Another data
collector interviews each parturients for the presence or absence of nausea and vomiting during
operation and every 2hours interval up to 6 hours postoperatively. Severity of nausea was
evaluated on a linear numeric scale which ranged from 0 to 10 (no nausea: 0; mild nausea: 1–3;
moderate nausea: 4–7; severe nausea: 8–10) at the end of surgery, at 2 hour, at 4hour, and at 6
hours; and number of vomiting episodes in study period. The type of analgesics given to
postoperative pain management was identified by the data collector.
93.8. Data Quality Control
To ensure quality of data, pre-test of data collection tools was done on patients by taking 14
respondents (7 who had got metoclopramide prophylaxis and 7 without any metoclopramide
prophylaxis) who undergone cesarean section under spinal anaesthesia and were not included in
the main study. After the pre-test the data collection tool were modified appropriately. Data was
checked for completeness, accuracy and clarity on the day of collection before entered in to
database by the Principal Investigator. Data clean up and cross-checking was done before
analysis. Training was given to data collectors for one day on how to approach study participants
on how to use the data collection tool. Continuous supervision was also done by principal
investigator.
3.9. Data Management and analysis
After completion of data collection, the data was checked for errors and coded to numerical
values and analysis done using spss version 20. The data were tested for normality using the
Shapiro-Wilk normality test and homogeneity of variance as assessed by Levene's Test for
Equality of Variances. Baseline demographic characteristics, anaesthetic and surgical
management and measures of effectiveness were compared between the study arms using
independent t-test for Normally distributed data and Mann Whitney U test (MUT) for non
normally distributed data and chi square or fisher`s exact test for categorical variables. Normally
distributed data presented as Mean ±SD and none normally distributed data presented as median
(IQR). Significance level < 0.05 considered statistically significant. Baseline characteristics and
risk level was checked for similarity in the groups.
3.10. Ethical considerations
Ethical clearance was obtained from the university ethical clearance committee before the start
of the study. The purposes and the importance of the study were explained & verbal informed
consent was obtained from each participant by the data collector. Confidentiality was maintained
at all levels of the study by avoiding identifiers and using codes to identify patients. Participant’s
involvement in the study was on voluntary bases, participants who were not willing to participate
in the study & those who wish to quit their participation at any stage was informed to do so
without any restriction
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4. Dissemination of results
The results of the study will be presented to the department of anaesthesia as part of Msc in
advanced clinical anaesthesia thesis, communicated through annual students and staff research
conference, annual National conference of Ethiopian Anesthetists Association (EAA) and will be
sent to the EMJ. The results will also be disseminated to those who can advocate and implement
them.
5. Result
5.1. Socio-demographic characteristics of participant:
In this prospective observational study one hundred thirty two emergency cesarean section
mothers were enrolled. All cesarean section performed for varieties indications (cephalopelvic
disproportion, fetal distress, and failed induction, prolonged rupture of membrane,
malpresentation, previous scare and me conium stain). Of these sixty six were mothers who get
10 mg metoclopramide prophylaxis before cesarean section (Group A) and the rest sixty six who
were not given the prophylaxis classified as Group B. 13 mothers were having history of surgery
and none them had history of smoking. The socio-demographic characteristics (age, weight,
height, ASA status, fasting hours and history of PONV / motion sickness) were comparable in
both groups, as shown in table 1.
11
Table 1: Socio-demographic characteristics mothers who underwent emergency cesarean section
at GUH in each group, April 2014, North West Ethiopia.
Group A Group B p-value
Characteristics (n=66) (n=66)
Age(yr) 26.71±4.61 27.33± 5.81 0.498
Weight(kg) 60.03±7.03 58.03±6.63 0.095
Height(cm) 161.77±4.69 161.07±4.77 0.399
ASA (I/II) 62/4 65/1 0.365
Gravidity -primi-gravida 29(43.9%) 34(51.5%) 0.384
-Multi-gravida 37(56.1%) 32(48.5%)
History of PONV/motion sickness 17(25.8%) 21(31.8%) 0.442
Duration of surgery(min) 51.97±10.51 50.59±11.15 0.466
Duration of uterus exteriorized(min) 21.70±5.92 20.32±5.79 0.179
Fasting hours  before cesarean section 0.315
shorter than 6hrs 19(28.8%) 14(21.2%)
longer than 6hrs 47(71.2%) 52(78.8)
Values are given as mean±SD, (%), student t-test and chi-square by 2x2/ (2x>2) table, α < 0.05
significant
5.2. Baseline perioperative anaesthetic and surgical characteristics of participants
Baseline perioperative anaesthetic and surgical characteristics of the parturients such as duration
of surgery amount of fluid coloaded, total estimated blood loss, number of patients having
hypotension after spinal and type of analgesic given for intraoperative postoperative pain
management were observed and they were comparable in each group. None of anaesthetists used
15 degree left lateral tilt and no patient was observed to have pulse rate less than 50 during
surgery in both groups in the study period. Ten mothers were on induction with oxytocin, 54.5%
of patients experienced more than three grade shivering during cesarean section and
supplemental oxygen were given for forty two percent of the total study participants but it was
comparable between the two groups. The only antibiotic prophylactic given during the study
period was ceftriaxone.
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Table 2: Baseline perioperative anaesthetic and surgical characteristics of each group of mothers
who undergo emergency cesarean section at GUH, April to March 2014, Northwest Ethiopia
Group A Group B P-value
Characteristics (n=66) (n=66)
Type of local anesthetics given for block 0.302
0.5% isobaric bupivacaine 29(43.9%) 30(45.53%)
0.5% heavy bupivacaine 26(39.4%) 19(28.8%)
2% Lidocaine with adrenaline 11(16.7%) 17(25.8%)
Level of sensory block at the start of at the
time of incision
T6 (T7- T6) T6 (T8-T6)
pain complain during surgery 18(27.3%) 25(37.9%) 0.194
type of uterotonic drugs 0.980
oxytocin bolus 20 22
oxytocin infusion 23 23
Ergometrine 12 11
oxytocin + Ergometrine 11 10
Amount of fluid coloaded 1200(300) 1200(400) 0.085
Total fluid during surgery 1874.24±501.08 1867.27±725.76 0.932
Estimated blood loss during surgery 1050(420) 920(400) 0.078
Fall in SBP >20% from the baseline 36(54.5%) 26(39.4%) 0.081
Analgesic drugs during surgery 0.151
Tramadol(im) 18(27.3%) 26(39.4%)
Diclofenac (im) 0 1
postoperative analgesic drugs 0.134
Tramadol (im) 46(69.7%) 35(53%)
Diclofenac (im) 17(25.8%) 25(37.9%)
tramadol and  diclofenac 3(4.5%) 6(9.1%)
Values are given as mean±SD, median (IQR), n (%), student t-test/MUT and chi-square by 2x2/ (2x>2)
table, α < 0.05 significant
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5.3. The incidence and severity of intraoperative and early postoperative (0-6hrs)
nausea and vomiting
In this observational study, the overall incidence of nausea and vomiting within six hours
following cesarean section was 25.8 %( 17/66) in metoclopramide and it was 48.5 % (32/66)
none metoclopramide group. There were significant differences between groups experiencing
nausea and or vomiting. The number of episode of vomiting was significantly lower in Group A
compared to group B during and after cesarean section as shown in table 3.
Table 3: The incidence of intraoperative and postoperative (0-6hrs) nausea and or vomiting in
each group of patients who underwent emergency cesarean section at GUH, April 2014, North
West Ethiopia
parameters
Group A
(n=66)
Group B
(n=66)
p-value
Intraoperative nausea 14(21.2%) 26(39.4%) 0.023
vomiting 7(10.6%) 18(27.3%) 0.015
Early postoperative(0-6hr) nausea 3(4.5%) 9(13.6%) 0.069
vomiting 1(1.5%) 7(10.6%) 0.029
overall  (intraop - 6hrs) nausea and or vomiting 17(25.8%) 32(48.5%) 0.007
Values refer numbers (%) of patients, chi-square/fisher’s exact test, and α < 0.05 significant.
In this study the median nausea NRS score experienced by patients during and after CS in each
time interval were analyzed. The median value in each interval of time did not clearly show good
comparison between groups due to nature of data distribution. The median nausea for group
A(metoclopramide group) was significantly lowers than group B at the end of CS, 2hr and 4hr
after surgery. Hover ever there was no significant differences severity of nausea at 6hours after
CS. (table 4)
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Table 4: The comparison of severity of nausea and vomiting between groups
time group A(n=66) group B( n=66) P-value
At the end of surgery 0(0-7) 0(0-9) 0.037
At 2hr 0(0-6) 0(0-9) 0.006
At 4hr 0(0-6) 0(0-8) 0.031
At 6hr 0(0) 0(0-3) NS
vomiting episodes 0.004,df=3
0 59(87.9%) 41(62.1%)
1 6(9.1%) 14(21.2%)
2 2(3%) 7(10.6%)
3 or more episodes 0 4(6.1%)
Values are presented as median (interquartile range), number (%), p<0.05 significant.
6. Discussion
Spinal anesthesia for cesarean section is preferred anaesthetic technique in most of the setup in
the world. Nausea and vomiting after cesarean section are distressing condition that affects up to
80% of cases.[2, 39] The etiology of nausea and vomiting during cesarean section under spinal
anaesthesia is complex, and dependent on variety of factors. Hypotension is one offending factor
which may cause brain-stem hypoxia and, thus triggers the vomiting center to cause nausea and
vomiting. Rapid fluid infusion left uterine displacement, prophylactic vasopressors slow
administration of oxytocin advocated to minimize hypotension.[1, 8, 11, 40, 41]In our study; the use
of these relative preventive measures were observed less due to in availability and difficulty to
apply during emergency cesarean section in our setting. But these factors were comparable
between the study groups.
In addition maternal demographics such as age, previous history of motion sickness or
postoperative nausea or vomiting [4], pain during uterine exteriorization and peritoneal traction
and anaesthetic management considered to affect the occurrence of nausea and vomiting during
cesarean section and postoperative period.[37] In this study however, these factors were found
balanced between the groups, so that the difference in the incidence of nausea and or vomiting
during cesarean section and early postoperative period could be attributed by drug.
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In this prospective observational study emergency cesarean section under spinal anaesthesia
were included to assess the effects of prophylaxis metoclopramide in the incidence and severity
of nausea and vomiting during cesarean section and early postoperative(0-6hours) period. The
incidence of nausea and or vomiting were significantly reduce in the metoclopramide group
when compared none prophylaxis group (25.8% vs. 48.5%, p=0.007).The frequency and number
of vomiting episodes during and after surgery were also significantly reduced. The result was
consistent with a number of other previous studies done in India, Iran.[16, 34-36] The effect of
metoclopramide and acupressure were compared with placebo on severity of nausea on a linear
numeric rating scale in elective cesarean section under spinal anesthesia. This study found that of
found that the mean nausea score at 30 minute, 60 minute, 90 minute, 120 minute,2hour, 4hour
and 6hour after surgery was significantly reduced compared the placebo.[36] In our study; median
numeric nausea score experienced during cesarean section, at 2hr and 4hour postoperative was
significantly reduced in the metoclopramide group, but it was comparable at 6 hours post
operative time. The reason for this discrepancy may be difference in postoperative pain
management, the use of local anesthetics spinal anesthesia and use of weak opoid and NSAIDs
for postoperative pain managements that would affect postoperative nausea. The validity to
understand the measurement tool might also differ depending on the level of education.
Metoclopramide is a prokinetic drug that acts by increasing the tone of the lower oesophageal
sphincter. It also has an antidopaminergic action on the chemoreceptor trigger zone and at higher
doses has an anti serotonergic activity. The onset of action after i.v. administration of 10 mg is 1-
3 minutes and its half life is approximately 3-4 hours.[1] At lower dose (10mg) was found
ineffective in non obstetric surgery under general anesthesia. But previous systematic reviews
and majority of randomized controls reported; this dose was found to be effective and safe to
reduce the incidence of IONV and PONV in women undergoing cesarean section under regional
anesthesia when it was administered prior to block placement as well as after delivery.[16, 20, 34]
Some of adverse effects this drug includes sedation, agitation, extra pyramidal and Parkinson
symptoms in some cases.[1]
Limitations of the study
The limitation of this study is neither controlled nor randomized observational, we could not
control variations in the anaesthetic and surgical techniques and the use of different drugs which
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may have confounding. Some variables such as estimated blood loss, amount of fluid preloaded
were difficult to measure accurately. The follow up time was short to compare the overall
incidence postoperative nausea and vomiting.
Strengths of the study
The strength of this study; it was the first to include emergency cesarean section with different
indication for cesarean delivery.
Appropriate analysis methods suitable for nature of variable were used. And inclusion of patients
with variety of anesthetic and surgical intervention makes the result generalizable for the
university hospitals.
7. Conclusion
Metoclopramide can reduce the incidence and severity of nausea and vomiting when used as
prophylaxis before emergency cesarean section under spinal anesthesia.
8. Recommendations
Administration of metoclopramide can reduce the incidence and severity of intraoperative and
early postoperative nausea and vomiting when used as prophylaxis before emergency cesarean
section under spinal anesthesia. However, this result needs further confirmation of 24 hours
effectiveness of metoclopramide with randomization and controlling of confounding factors.
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10. Annexes
Annex I: Information Sheet
Title of the Research Project
Assessment of the effectiveness of metoclopramide prophylaxis on the reduction of nausea and
vomiting following cesarean section under spinal anaesthesia in GUH, North West Ethiopia.
Name of Principal Investigator – Nigussie Simeneh (BSc in Anesthesia)
Name of advisors: Adugna Aregawi (MSc)
Habtamu Getnet (MSc)
Name of the Organization: University of Gondar, College of Medicine and Health Sciences,
Department of Anesthesia
Name of the Sponsor: University of Gondar Hospital
Introduction
This information sheet is prepared with the aim of assessing effectiveness of prophylaxis
metoclopramide in the prevention of intraoperative and early post operative nausea and vomiting
prophylaxis following cesarean section under spinal anaesthesia in GUH. The research group
includes the principal investigator two data collectors, and two advisors from University of
Gondar.
Purpose of the Research Project
The aim of this study is to determine effectiveness of prophylaxis metoclopramide in the
prevention of nausea and vomiting following cesarean section under spinal anaesthesia in GUH.
Assessing the effectiveness of metoclopramide prophylaxis for nausea and vomiting in patients
during cesarean section under spinal anaesthesia is very important to reduce the incidence and
severity of nausea and vomiting during cesarean section under spinal anaesthesia by giving
appropriate prophylaxis or other preventive measures. The results of this study will be used to
design appropriate intervention programs to reduce the occurrence of intraoperative and post
operative nausea and vomiting GUH, as well as in other health institutions in Ethiopia.
Procedure
This study will involve candidate parturients coming for operation under spinal anesthesia in the
time interval between February -April /2014. Each Study participants will be selected to be one
22
of the study participants if they are willing to participate in this study and ready to give oral
consent.
Benefits, Risk or Discomfort
There is no risk to the participants in participating in this research project because of there is will
not be any interventions taken other than observation and some brief interview after CD.
However, your participation is definitely important to assess the effectiveness of metoclopramide
for nausea and vomiting following cesarean delivery under spinal anesthesia in GUH, to identify
factors associated to the intraoperative and postoperative nausea and vomiting and to design
appropriate strategy to decrease the incidence of the nausea and vomiting in both groups.
Confidentiality
The information collected from study subjects will be kept confidential and stored in a file,
without your name by assigning a code number to it. And hence no report of the study ever
identifies the participants.
Right to Refusal or Withdraw
They will have the full right to refuse from participating in this research. They have also the full
right to withdraw from this study at any time they wish.
Person to contact
For any questions or concerns you can contact the principal investigator using the following
addresses:
Name: Nigussie Simeneh
Telephone: +251 918 441203
E-mail:simenehn@gmail.com
Annex –II:  Severity of nausea and vomiting
 Severity of nausea will be classified as mild, moderate and severe according to the numerical
rating Scale as follows
0 10cm
No nausea worst imagnable nausea
Annex– III: Amharic Version Questionnaire Guide
ጤና ይስጥልኝ፡ስሜ-----------ይባላል፡፡ በጎንደር ዩኒቨርሲቲ አንስቴዝያ ትምህርት ክፍል የምርምር ቡድን ውስጥ እየሰራሁ
እገኛለሁ፡፡ ወደዚህ የመጣሁበት ምክንያት ከወገብ በታች በቀዶ ህክምና የሚሰጥ ማደንዘዣ ተከትሎ ሊከሰት ስለሚችል
23
የማቅለሽለሽ እና ትውኪያ መጠን ለሚደረገው ምርምር /ጥናት መረጃ ለመሰብሰብ ነው፡፡ ጥናቱን የሚያካሂዱት በጎንደር
ዩኒቨርስቲ አንስቴዝያ ት/ክፍል የሁለተኛ ድግሪ ተማሪ የሆኑት ንጉሴ ስሜነህ ናቸው፡፡
ስለዚህ ከአስር እስከ ሀያ ደቂቃ የሚሆን ጊዜ የሚወስዱ ጥያቄዎች አሉኝ፡፡ የርስዎ ጥያቄዎችን መመለስ ከወገብ በታች
ማደንዘዣ ተሰጥተዎት በቀዶ ህክምና ሲወልዱ ሊከሰት ስለሚችል ማቅለሽለሽ እና ትውኪያ ለመቀነስና ለመከላከል ከፍተኛ
የሆነ አስተዋፅዎ ይኖረዋል፡፡ ከዚህ የሚገኘው ማንኛውም መረጃ በሚስጥር ይጠበቃል፡፡ ለዚህም ሲባል የርስዎ ስም
አይፃፍም፡፡ ለመመለስ ፈቃደኛ ያልሆኑትን ማንኛውም ጥያቄ አለመመለስም ይችላሉ፡፡ በማንኛውም ስዓት የጥያቄና መልሱን
ሂደት ማቐረጥ ይችላሉ፡፡ ነገር ግን ቀደም ሲል እንደተገለፀው እርስዎ የሚሰጡት እዉነተኛ ምላሽ ከወገብ በታች በቀዶ
ህክምና የሚሰጥ ማደንዘዣን ተከትሎ ሊከሰት ስለሚችል የማቅለሽለሽ እና ትውኪያን ለመቀነስና ለመከላከል ለሚደረገዉ
ምርምር / ጥናት በከፍተኛ ሁኔታ ያግዛል፡፡
የቃል ስምምነት
የዚህ ጥናት ዓላማ ተነቦልኝ (አንብቤው) እና አላመው ገብቶኝ በጥናቱ ለመሳተፍ
ሀ. ፈቃደኛ ሆኛለሁ--------------------- (ቃለ መጠይቁን መቀጠል ይችላሉ)
ለ. ፈቃደኛ አይደለሁም………………………..(ቃለ መጠይቁን ያቁሙ)
ፈቃደኛ ከሆኑ
የጥያቄው መለያ ቁጥር ……….. መጠይቁ የሚካሄድበት ቀን------------- የተጀመረበት ስአት………………
የጠያቂው ስም ና ፊርማ-------------------------- --------------------------
የሱፐርቫይዘር ስም ና ፊርማ----------------------- --------------------------
Annex – IV: English Questionnaire
This questionnaire is to be used as a guide to collect information for the data collectors!
Questionnaires to assess effectiveness of prophylaxis metoclopramide
intraoperative and 6 hours post operative nausea and vomiting during cesarean
section under spinal anaesthesia in GUH, North West Ethiopia.
Hello! My name is --------------I am one of the members of the research team. The purpose of this
questionnaire is to gather information on effectiveness prophylaxis metoclopramide in reducing
intraoperative and post operative nausea and vomiting during cesarean section under spinal
anaesthesia in GUH. I have identified you as a study participant hoping that you would be
willing to help me by providing some information. I have some questions which I would like to
ask you, if you have the time and are willing. Your participation is definitely important to assess
the effectiveness of metoclopramide prophylaxis for nausea and vomiting following cesarean
delivery under spinal anesthesia in GUH. All information you provide will be kept confidential. I
will not include any identifiers, such as your name or exact address. Only honest answers would
24
contribute to improvement of health planning. Your role in the success of the research is
important and I appreciate your contribution to the research. Would this be okay with you?
I understood about the advantage of the research and the roles I will have in the research. I have
agreed to participate in the research.
A. Agree          B. disagree
If Respondent agrees to be interviewed, the interview will be started
Questionnaire Code ________
Starting time ______________ finishing time ________________
Date of data collection________________________________
Name of data collector_____________________________signature_______________
Instruction: For each of the following questions, please circle the number of alternative(s)
that fit the response or fill the blank space!
SECTION I: maternal characteristics and predictor risk factors
S.No Questions response
101 maternal age _______________yrs
102 weight _____________kg
103 ASA A.  ASA I         C. ASA III
B.  ASA II         D. ASA IV
104 height ______________cm
105 parity _________
106 Indication for cesarean section? ____________________specify.
107 Did you have smoking history? A. Yes
B. No
108 Have you history of surgery and
anaesthesia?
A. Yes
B. No
109 If yes; have you ever have nausea and
or vomiting postoperatively?
A. Yes
B. No
110 Have history of nausea or vomiting
while travelling by car
A. Yes
B. No
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SECTION II: baseline preoperative characteristics of patients and interventions
S.No Questions response
201 was patient on oxytocin infusion before
C/S
A. Yes
B. No
202 What was prophylactic antibiotic given? A. Ampicillin
B. Ceftriaxone
C. Others________specify
203 Amount of fluid  preloaded within 30
minutes before spinal block ________ml
204 Fasting hours before cesarean section? A. less than 6 hours
B. greater than 6 hours
205 Base line BP at ward,  two measurement
before SAB in OR ______/______/______mmHg
206
Base line  PR at ward,  two measurement
before SAB in OR
_____/_______/________bpm
Section III: intraoperative anesthetic and surgical interventions.
S.No. questions response
type and baricity of local anesthetics
used
A. heavy bupivacaine
B. isobaric bupivacaine
C. 2 % Lidocaine with adrenaline
D. 2 % Lidocaine without adrenaline
301 Volume of local anesthetic? _______________ml
302 Sensory block level before delivery? ______________
304 Does the complain pain during
surgery?
A. yes
B. no
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305 If yes, is any intraoperative
intravenous supplemental analgesia
given?
A. yes
B. no
306 If yes, what is given?( total doses
intraoperative period)
A. Morphine____________mg
B. Fentanyl_____________mg
C. Tramadol____________mg
D. Diclofenac___________mg
E. pethidine ____________mg
307 Does left lateral tilt or 15 degree
wedge uterine displacement used?
A. yes
B. no
308 Total amount blood loss including
amontic fluid during surgery _______________ml
309 Total intraoperative fluid given
during the operation. _______________ml
310 What was given? A. Normal saline
B. Ringer lactate
C. DNS
D. DW
E. Other ____________ specify
311 Duration of surgery _______________minutes
312 Duration uterus exteriorized? _____________minutes
313 What type of uterotonic agent was
administered after delivery?
A. Oxytocin bolus _______ IU
B. Oxytocin infusion ________IU
C. Ergometrine_____mg(iv/im,)
D. Others_____________specify
314 Does  patient experience  shivering
after spinal anesthesia
A. yes
B. no
315 Does supplemental oxygen given
during the operation?
A. yes
B. no
SectionIV:  Hemodynamic measurements during surgery and 6hours postoperative
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S.No. questions response
401 BP (mmHg)  at 5, 10, 15,
20, 30,40 minutes after
SAB
____/________/________/_____/_______
402 PR at 5, 10, 15, 20, 30
minutes after SAB. ____/______/______/_____/_____
403 Sao2   at 5, 10, 15, 20, 30
minutes after  SAB _____/______/_____/_____/____%
404 Was to treatment given for
HPT or bradycardia?
A. yes
B. no
405 if yes ; what was given A. adrenaline
B. atropine
C. dopamine
D. others________specify
406 BP every 1hour interval ________/ ________/_______
________/_______/_______mmHg
406 PR every 1hour interval _____/ ____/______/____/_______/_______
Section V: The characteristics based on frequency and severity of nausea and vomiting in
the intraoperative period, early postoperative period (0-6 hours).
S.No
.
questions response
501 Did you experiences nausea and or
vomiting following spinal anesthesia?
A. yes
B. no
502 If yes, when it was happened?(follow Q503
to 506)
A. during operation
B. early postop (0-6hours)
503 If yes specify your nausea or
vomiting i.e. where is your
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possible feeling to nausea?
Based on Visual analogue scale(
mark specific interval)
( assess the intraoperative
VAS immediately after
transfer to ward)
episode
nausea
vomiting ___
504
episode
at  first 2hours
nausea
vomiting ____
505
episode
at second 2hour
nausea
vomiting ____
506
episode
at 3rd 2hour
nausea
vomiting ____
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Section VI: postoperative managements in the 6hours post-op period (from chart review and
interview).
S.No. questions response
601 When was experience pain after surgery? A. within 2 hours
B. between 2-4 hours interval
C. between 4-6 hours interval
602 If yes, Was any analgesia given for
postoperatively pain management?
A. yes
B. no
603 If yes, what was given?(Total dose given
over in 6hours postoperatively)
A. Morphine_______mg
B. Fentanyl ________mg
C. Tramadol_______mg
D. Pethidine _______mg
E. NSAIDs_________mg
F. Others ___________ specify
604 When was it given? A. within 2 hours
B. between 2-4 hours interval
C. between 4-6 hours interval
506 Does any antiemetic administered
postoperatively within 6hours
A. yes
B. no
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